Ion Exchange (India) Limited (500214) Fair Value & Analysis
Other · IN · Market cap ₹8.2B
Fair value as of: Jul 4, 2026
From 14 valuation models · updated 5 days ago
Share price +18.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹317.15 – ₹565.34 · fair‑value band ₹873.31 – ₹1,547 · the ₹418.55 price screens below the ₹1,238 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Ion Exchange (India) Limited (500214) currently trades at ₹418.55, while our model-based Fair Value estimate is ₹1,238 — implying the stock looks roughly 195.8% undervalued today. We read business quality at 44/100 (below-average quality), in the Other sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Net debt stands at ₹2.7B. The stock trades on a trailing P/E of 8.3. Fundamentals as of Jul 4, 2026
Our scenario range runs from ₹873.31 (bear case) to ₹1,547 (bull case); at ₹418.55, the current price sits below that range. The share trades about 28% below its 52-week high and 34% above its 52-week low. For context, the median of 10 Other peers we cover trades at -16% fair-value upside — at 196%, 500214 screens cheaper than that median.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Ion Exchange (India) Limited provides water and environment management solutions in India and internationally. The company operates in three segments: Engineering, Chemicals, and Consumer Products. It offers water, waste water treatment, and recycling plants using various physico-chemical processes for settling, clarification, filtration, disinfection, membranes and ion exchange technology, and ion exchange resins; polymers and polyelectrolytes for water and non-water processes; and boiler cooling water and fireside treatment chemicals. The company also offers integrated services, such as service/O&M contracts, equipment modification, RO service and monitoring, water audits, and consumables replacement; and supplies spares. It serves various industries, such as automotive, cement, chemicals, electronics, food and beverage, fertilizers, paper and pulp, pharma, power, refinery and petrochemical, steel and metallurgy, mining and minerals, sugar, and textiles; educational, hospitality, …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Ion Exchange (India) Limited reported revenue of ₹29.1B in FY2026 versus ₹15.8B in FY2022, a compound +16.6%/yr. Reported net income was ₹1.4B in FY2026, compounding −3.2%/yr from FY2022.
Is 500214 fairly valued? → Check now
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €269.92 | -48% |
| Sony Corporation SON1 | €17.58 | €37.56 | +114% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $64.93 | +286% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
| 540777 540777 | ₹567.55 | ₹142.69 | -75% |
| Lupin Limited 500257 | ₹2,476 | ₹2,372 | -4% |
| 540719 540719 | ₹1,788 | ₹850.02 | -52% |
| 524804 524804 | ₹1,620 | ₹1,368 | -16% |
Explore undervalued stocks
Frequently asked questions
Is Ion Exchange (India) Limited (500214) undervalued?
What is the fair value of 500214?
What is the quality score of 500214?
What is the net profit margin of 500214?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.